EQT X, through its indirectly owned subsidiary Oak BidCo S.à r.l., has secured an ownership of 72.5% of the votes in OEM International Aktiebolag (publ) and has announced a public cash offer to all shareholders. The shares of OEM International are admitted to trading on Nasdaq Stockholm, Mid Cap. The total value of the offer is approximately SEK 15.2 billion.

OEM International is one of Europe's leading technology trading companies with 34 operating units in 15 countries. The group operates in the trade of components and systems from leading suppliers in selected markets in Europe. A well-structured local market organisation and efficient logistics make OEM a better alternative to the supplier’s own sales organisations.

Vinge’s team mainly consists of Sofie Bjärtun, Erik Sjöman, Joel Magnusson, Maximilian Bengtsson and Lovisa Jonassen (Capital Markets and Public M&A), Christina Kokko and Eléonore Friberg (M&A), Sebastian Örndahl, Noelia Martinez, Julia Rydin and Martin Hammarskiöld (Regulatory), Josefine Lanker (Banking and Finance), Christoffer Nordin and Elis Allmark (Commercial Agreements), Niclas Winnberg (Real Estate), Ebba Svenburg (Employment), Arvid Axelryd (Intellectual Property), Eva Fredriksson (IT), Hayaat Ibrahim (Compliance), Nicklas Thorgerzon (GDPR) and Julia Ulander Kull (Transaction Support Coordinator).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025